04:21 PM EDT, 03/12/2025 (MT Newswires) -- Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer, on March 10, 2025, sold 3,242 shares in Vertex Pharmaceuticals ( VRTX ) for $1,620,968. Following the Form 4 filing with the SEC, Tatsis has control over a total of 51,239 common shares of the company, with 51,239 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/875320/000087532025000146/xslF345X05/wk-form4_1741810227.xml